Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute

Joan Montaner1, Alex Rovira, Carlos A Molina

  • 1Neurovascular Research Laboratory, Stroke Unit, Vall d'Hebron Hospital, Barcelona, Spain. 31862jmv@comb.es

Insights

Matrix metalloproteinase-9 (MMP-9) levels predict infarct volume in acute middle cerebral artery stroke. Hypoperfused brain areas correlated with increased pro-inflammatory cytokines like tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6).

Area of Science:

  • Neuroscience
  • Biochemistry
  • Radiology

Background:

  • Acute stroke involves complex neuroinflammatory processes.
  • Accurate prediction of infarct volume is crucial for treatment decisions.

Purpose of the Study:

  • To correlate neuroinflammatory markers with MRI-derived lesion volumes in acute middle cerebral artery stroke.
  • To identify predictors of infarct size and associated inflammatory responses.

Main Methods:

  • Serial measurement of plasmatic neuroinflammatory markers (MMP-9, MMP-2, IL-6, IL-8, ICAM-1, TNF-alpha) using ELISA.
  • Perfusion-weighted imaging (PWI) and diffusion-weighted imaging (DWI) MRI performed on 16 acute stroke patients within 6 hours of arrival.
  • Linear regression analysis to assess correlations between markers and lesion volumes.

Main Results:

  • Baseline matrix metalloproteinase-9 (MMP-9) was the sole significant predictor of diffusion-weighted imaging (DWI) infarct volume (b = 0.50, P < 0.001).
  • The extent of hypoperfused brain areas on perfusion-weighted imaging (PWI) correlated with subsequent release of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6).

Conclusions:

  • MMP-9 is a key predictor of infarct size in acute middle cerebral artery stroke.
  • Cerebral ischemia triggers a pro-inflammatory response, with hypoperfusion linked to cytokine release.